Pay in 4 interest-free payments of $6.94 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Visit our contact page to get expert guidance and look at our products for better and more informed choices
Zepbound (tirzepatide) Zepbound is a dual GLP-1 and GIP receptor agonist medication
The forward-looking statements contained in this press release are made only as of May 20, 2026
Although still under clinical investigation, early results suggest retatrutide may offer benefits beyond traditional treatments
Bills like the Treat and Reduce Obesity Ac t would allow Part D to cover FDA-approved weight-loss drugs more broadly, but as of late 2025, no such law has passed.
Pereira, C.M
US$ 27.36
US$ 29.17
US$ 24.55
US$ 25.94
US$ 20.36
US$ 28.41
US$ 24.28
